Many techniques for studying functional genomics of important target sites of anthelmintics have been restricted to Caenorhabditis elegans because they have failed when applied to animal parasites. To overcome these limitations, we have focused our research on the human nematode parasite Brugia malayi, which causes elephantiasis. Here, we combine single-cell PCR, whole muscle cell patch clamp, motility phenotyping (Worminator), and dsRNA for RNAi for functional genomic studies that have revealed, in vivo, four different muscle nAChRs (M-, L-, P-, and N-). The cholinergic anthelmintics had different selectivities for these receptors. We show that motility and patch-clamp responses to levamisole and pyrantel, but not morantel or nicotine, require the unc-38 and/or unc-29 genes. Derquantel behaved as a competitive antagonist and distinguished M-nAChRs activated by morantel (K b 13.9 nM), P-nAChRs activated by pyrantel (K b 126 nM), and L-nAChRs activated by levamisole (K b 0.96 μM) and bephenium. Derquantel was a noncompetitive antagonist of nicotine, revealing N-type nAChRs. The presence of four diverse nAChRs on muscle is perhaps surprising and not predicted from the C. elegans model. The diverse nAChRs represent distinguishable drug targets with different functions: Knockdown of unc-38+unc-29 (L-and/or P-receptors) inhibited motility but knockdown of acr-16+acr-26 (M-and/or N-receptors) did not.
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filaria | Brugia | dsRNA | nAChR | patch clamp T he neglected tropical diseases caused by nematode parasites affect some 2 billion people globally, and effective vaccines are not available. Although these parasites by themselves do not produce high mortality, they produce significant morbidity that affects worker productivity and increase susceptibility to AIDS and malaria, and they are strongly associated with poverty in endemic countries (1) (2) (3) (4) . There are only a limited number of classes of anthelmintic drugs that are used to treat these diseases, and there are concerns about the development of resistance (5) . There is a pressing need to advance the study of anthelmintic drugs.
Many useful studies on modes of action of anthelmintic drugs have been conducted on the model nematode, Caenorhabditis elegans, but this is not a parasite: It is separated evolutionarily by millions of years from parasitic nematodes and it does not possess "parasitism genes" (6) . This separation increases the impetus for anthelmintic studies using real parasites, but until now many techniques developed in C. elegans have not have been tractable when applied to animal parasites (7) .
The neuromuscular systems of nematodes, which control motility and support feeding, growth, and reproduction, are governed by significant parts of their gene pools (8, 9) . Their neuromuscular systems are unlike those of vertebrates because nematode muscles send processes to the motor neurons to form synapses, rather than the other way around. Membrane ion-channels, which regulate nematode neuromuscular systems, are target sites of major classes of anthelmintic drugs, including the cholinergic anthelmintics levamisole, pyrantel, and derquantel (10) (11) (12) (13) (14) (15) (16) (17) . Here, we have combined a number of techniques for the study of muscle pentameric acetylcholine receptor channels (nAChRs) of the filarial nematode parasite, Brugia malayi. Filariasis is one of a group of neglected tropical diseases caused by clade III parasitic nematodes that are transmitted by biting insects. B. malayi adults are found in the lymphatic vessels of humans, producing lymphatic filariasis, sometimes associated with swelling of the limbs (elephantiasis). B. malayi is also a suitable model parasite because it can be maintained in laboratory rodents, unlike a more common cause of lymphatic filariasis Wuchereria bancrofti. Lymphatic filariasis occurs in some 120 million people in developing countries, and regrettably, effective treatments for adult filaria infections are limited. Although a triple combination of ivermectin, diethylcarbamazine, and albendazole seems to be effective (18) , development of new treatments to kill adults is still required (19, 20) . Cholinergic anthelmintics (levamisole, haloxon) are not regularly used for the treatment of B. malayi, but there are reports of their efficacy (21, 22) that have encouraged us to study their nAChRs as anthelmintic targets.
To study the functional genomics of nAChRs of B. malayi, we used the following: (i) video capture for quantitative phenotyping (23, 24) ; (ii) single-cell PCR to identify nAChR subunit genes expressed in muscle (25) ; (iii) dsRNA for RNAi knockdown of unc-38+unc-29 of nematode levamisole and pyrantel receptors (26, 27) , and (iv) whole-cell patch clamp to record functional properties of muscle nAChRs (10, 28) . Knockdown of acr-16+acr-26 had little effect on motility, but knockdown of unc-38+unc-29 abolished motility, suggesting in B. malayi that different physiological functions may be ascribed to different receptors. Our observations revealed that there are four types of nAChR in B. malayi muscle.
Significance
Methods for studying functional genomics of ion-channel target sites of antinematodal drugs (anthelmintics) have been limited to the model nematode Caenorhabditis elegans because many techniques for studying animal parasitic nematodes have been unsuccessful. Here, we develop preparations of the human parasite Brugia malayi, which causes elephantiasis, to allow us to combine RNAi, PCR amplification of RNA from single muscle cells, computer analysis of movement, and patch-clamp electrophysiology to study the action of cholinergic anthelmintics. We find that they are not a homogenous class of drugs and that they act selectively on four distinguishable, M-, L-, P-, and N-acetylcholine ion-channel receptors. These four receptors are distinct druggable targets with different physiological functions.
Two types, which require UNC-38 and/or UNC-29 subunits, support motility: They are the L-type, which is preferentially activated by levamisole, and the P-type, which is preferentially activated by pyrantel. The two other types, which persisted in the absence of UNC-38 and UNC-29 and which did not maintain motility, were the M-type, which was preferentially activated by morantel and preferentially antagonized by derquantel, and the N-type, which was preferentially activated by nicotine. Separation of the four muscle receptors is significant and contrasts with the model nematode, C. elegans, where only N-and L-receptors are recognized (29) . The four receptors could be targeted by future combinations of single receptor selective cholinergic anthelmintics or one that is equally potent on all of the receptors. Either of these approaches are anticipated to overcome or slow the development of resistance due to mutation at a single receptor.
Results
Cholinergic Anthelmintics Inhibit Whole B. malayi Motility. Fig. 1A shows the concentration-dependent inhibitory effects of cholinergic agonist anthelmintics on motility of B. malayi adult females. The effects of each of these agonists were rapid and occurred within 5 min of application. We quantitated the motility of the adult B. malayi by using Worminator motility measurements at 5 min to compare the potencies of the anthelmintics. Levamisole was the most potent with an IC 50 of 99 ± 2 nM; pyrantel was less potent, IC 50 = 516 ± 30 nM; as was morantel IC 50 = 3.7 ± 0.7 μM; and nicotine, IC 50 = 4.8 ± 0.8 μM.
The potency series was: levamisole > pyrantel > morantel = nicotine. We also tested the effects of a cholinergic antagonist, derquantel, and found that it was the least potent of the anthelmintics on motility inhibition: Even high concentrations of derquantel (10 μM) only had a small (∼30%) inhibitory effect on motility (Fig. 1B) . Interestingly, despite a poor effect on motility, derquantel antagonized and inhibited the effects of the cholinergic agonists. Fig. 1B shows the inhibitory effect of derquantel on the actions of levamisole on wholeworm motility, indicating that its low potency inhibiting motility is not due to the failure to permeate the cuticle of B. malayi because it inhibits the effects of levamisole. To examine differences between the actions of these cholinergic anthelmintics, we conducted singlemuscle cell RT-PCR to identify nAChR subunits and whole-muscle cell patch clamp to characterize receptors.
Single-Cell PCR Reveals Expression of Multiple nAChR Subunits. We are able to collect cytoplasm from individual somatic muscle cells of B. malayi for PCR analysis. Suction on the whole muscle-cell patch pipette following recording allowed us to collect cytoplasm from single muscle cells. After collection of cytoplasm, the 2-mm tip of the patch pipette was broken off and placed in a single-step RT-PCR mix. We designed specific primer pairs (Table S1 ) to look for and were able to detect amplicons in each of six muscle cells per subunit: Bma-acr-8, Bma-acr-16, Bma-acr-21, Bma-acr-8, Bma-unc-63, Bma-unc-38, Bma-unc-29, and Bma-acr-26 ( Fig. 2A) , along with the housekeeping gene, gapdh (30). Although we confirmed the expression of Bma-acr-27 in whole B. malayi worms, expression in single muscle cells was more difficult to detect, and amplicons were visible only in 2 of 8 single muscle cells tested (Fig. S1 ). Recovery of mRNA for these different subunits encouraged the view that multiple nAChRs are expressed in single B. malayi somatic muscles and that the receptor types differ from those seen in C. elegans where only levamisole-sensitive, L-type, and the nicotine-sensitive, N-type, of nAChR are observed (31) . Clearly there are additional subunits present indicating the presence of additional nAChR subtypes.
Cholinergic Anthelmintic Agonist Effects on B. malayi Muscle nAChR
Currents. Fig. 2B shows a representative recording of the inward current responses to 100 μM acetylcholine followed by the effects of increasing concentrations of levamisole made on a muscle cell clamped at −40 mV: These current responses illustrate the presence of functioning nAChRs on B. malayi muscle cells. We tested other cholinergic anthelmintics in the same manner, and Fig. 2C shows log-concentration plots, normalized to the first application of 100 μM acetylcholine, for levamisole, pyrantel, morantel, nicotine, and bephenium. Acetylcholine had an EC 50 of 2.4 ± 0.6 μM; pyrantel had an EC 50 of 63.5 ± 0.2 nM; morantel had an EC 50 of 101.8 ± 0.4 nM; levamisole had an EC 50 of 3.4 ± 0.6 μM; bephenium had an EC 50 of 4.2 ± 0.1 μM with a reduced maximum response and; nicotine had an EC 50 of 30.1 ± 0.4 μM (n = 7 for all agonists). Thus, the EC 50 potency series was pyrantel > morantel >> acetylcholine = levamisole = bephenium >> nicotine. This potency series was different from the B. malayi whole worm motility assay with pyrantel and morantel being more potent than levamisole. One reason for the difference in the potency series is the cuticle barrier of B. malayi, which may be more permeable to levamisole, which is much less polar than pyrantel and morantel at pH 7.2.
Selective Antagonist Effects of Derquantel Distinguish Four Muscle nAChRs. We also tested morantel, pyrantel, levamisole, bephenium, and nicotine as agonists in the presence of the selective anthelmintic antagonist derquantel (n = 5). Fig. S2A shows Each point is the mean ± SE of four worms, each from a different batches of worms. Curves were fitted with variable slope nonlinear regression model analysis in GraphPad Prism 6. Concentration response curves for different agonists: LEV, levamisole 99.2 ± 2.3 nM; PYR, pyrantel 516 ± 3 nM; MOR, morantel 3.7 ± 0.7 μM; and NIC, nicotine 4.8 ± 0.8 μM (n = 4 for each concentration of agonist, four biological replicates). (B) Effects over time on motility of whole B. malayi of: 10 μM derquantel (Deq 10 μM); derquantel pretreatment followed by 10 μM levamisole (Deq 10 μM + Lev 10 μM, levamisole at the arrow); 10 μM levamisole (Lev 10 μM, levamisole at the arrow). Note that derquantel only has a modest effect on motility by itself, but clearly, it reduces the inhibitory effect of levamisole. n = 12, four biological replicates, two-way ANOVA and Bonferroni post hoc tests: ***P < 0.001; **P < 0.01.
representative current traces demonstrating that derquantel inhibited all of the agonists. Fig. S2B shows bar charts of the mean ± SE currents produced by the different agonists without, and then with, 1 μM derquantel for morantel, or 10 μM derquantel for the other agonists. The inhibition was significant (P ≤ 0.001, two-way ANOVA and Bonferroni post hoc tests) for all of the agonists and reversible on washing.
The effect of derquantel on concentration-response relationships for these agonists is shown in Fig. 3 . We fitted parallel concentration-response plots to quantify and describe the inhibitory action of derquantel by using the competitive antagonist model and determined the concentration ratios (CR) from the ratios. Derquantel had a potent effect on morantel, so we used 1 μM derquantel as the antagonist concentration and found the concentration ratio to be 74.8 ± 5.9 (n = 6). We calculated the dissociation constant, K b , for derquantel from the classic Gaddum-Schild equation:
where X b is antagonist concentration, K b is the antagonist dissociation constant, and CR is the concentration ratio. The K b for derquantel using morantel as the agonist was 14 nM. We used 10 μM derquantel with the other agonists because we found that it was less potent. The pyrantel concentration-ratio was 81.8 ± 5.2 (n = 6) and the K b was 126 nM; the levamisole CR was 12.6 ± 1.3 (n = 6) and the K b was 956 nM; the bephenium CR was 3.1 ± 0.3 (Fig. 3E) , demonstrating that nicotine activates a different population of nAChRs to the other agonists. Two-way ANOVA showed that the differences between the agonist CRs were significant (P < 0.001), and the Bonferroni multiple comparison tests showed that the CRs for 10 μM derquantel were significantly different for the agonists except for levamisole and bephenium. These observations show that morantel, pyrantel, levamisole, and nicotine activate different populations of receptors, but that levamisole and bephenium activate populations of nAChRs that were not distinguished by derquantel.
The derquantel inhibitory potency sequence is morantel >> pyrantel >> levamisole. We interpret our observations to indicate that there are four separable types of nAChR present on B. malayi muscle. The receptors preferentially activated by morantel and inhibited most by derquantel we refer to as the M-receptors, the receptors preferentially activated by pyrantel as the P-receptors, and the receptors preferentially activated by levamisole as the L-receptors. Because derquantel had a noncompetitive effect on nicotine in contrast to the effects on the other agonists, it demonstrates that nicotine acts on a different population of nAChRs. We refer to the preferred population of receptors activated by nicotine as the N-receptors. Fig. 3F is a schematic representation of the main pharmacological properties of these receptors and their putative subunit compositions.
Knockdown of unc-29 and unc-38mRNA Is High and Selective. RNAi has not been tractable when applied to animal parasitic nematodes, unlike the model nematode, C. elegans (32, 33) . Success using heterogeneous short interfering RNA (hsiRNA) mixtures has been reported with B. malayi (34) . We found that we did not need to use hsiRNA and that a high level of mRNA knockdown was achieved when we used 30 μg/mL of double stranded RNA (dsRNA) for 4 d. We designed and screened our dsRNA platform for adult B. malayi to knock down two specific nAChR subunit transcripts selected out of a group of some 30 nAChR subunits that might be present in the whole worms (30) . We targeted both UNC-29 and UNC-38 nAChR subunits, which contribute to putative levamisole-sensitive, L-type, and pyrantel-sensitive, P-type nAChRs in parasitic nematodes (14, 35) . We used two negative controls: an untreated (no added dsRNA) and lacZ from E. coli as a nonspecific dsRNA control that is not expressed in part or whole in nematodes. A dual-target dsRNA mixture delivery approach worked well and produced robust results in every experiment. Fig. 4A shows the high percentage of mRNA knockdown of unc-29+unc-38 (specific) dsRNA-treated worms compared with the lacZ dsRNA-treated worms: The mRNA levels of the other controls, GABA (unc-49) and GAPDH (gpd-1), remain little affected for both treatments. The mRNA levels were measured on single worms that were the same worms used for the day 5 electrophysiology recordings described later. We achieved significant (two-way ANOVA and Bonferroni post hoc, P ≤ 0.001) knockdown of transcript levels for unc-29 (95 ± 2.8%) and unc-38 (80 ± 6.9%) in the specific dsRNA-treated worms compared with modest change in the transcript level for unc-29 (7.3 ± 3.1%) and unc-38 (7.8 ± 2.9%) in the lacZ dsRNA-treated worms. We also tested whole worms for transcript knockdown for the nAChR subunits, ACR-26, ACR-27, and ACR-16. There was no significant knockdown in either of the nonspecific or specific dsRNA-treated worms (Fig. S3) .
dsRNA Knockdown of unc-29+unc-38 Produces a Motility-Inhibition Phenotype. We used the Worminator video tracking system to quantify, using pixel changes, the motility of the adult female worms exposed to specific (unc-29+unc-38) and lacZ (nonspecific) dsRNA over 5 d. Fig. 4B shows the recorded motility at daily intervals for control (untreated and lacZ dsRNA-treated) worms and test (unc38+unc-29 dsRNA-treated) worms. There was a large and significant (ANOVA, P < 0.001, n = 114) decrease in motility in the worms exposed to unc-29+unc-38 dsRNA by day 3 but only a modest decrease in motility in the control worms or lacZ-treated worms. These observations suggest that UNC-29 and/or UNC-38 are essential for maintaining the motility phenotype and that other nAChR subtypes, which do not contain UNC-29 and/or UNC-38 subunits, do not support motility. To test this hypothesis further, we conducted similar experiments and knocked down acr16+unc-26 and found that in contrast to knockdown of unc-38+unc-29, there was little effect on motility (Fig. S4) .
Only Levamisole and Pyrantel Currents Are Sensitive to unc-29+unc-38 Knockdown. dsRNA directed-target knockdown reduced transcript and motility levels (Fig. 4) and also changed the responses to agonists (Fig. 5) . We tested the whole muscle-cell current responses of the two controls (untreated and lacZ, n = 16 for both) and dsRNA-treated (unc-29+unc-38, n = 16) worms to fixed concentrations of acetylcholine, levamisole, nicotine, morantel, pyrantel, and bephenium on day 5. We included GABA, which is an inhibitory transmitter in nematodes, and which does not activate nAChRs as an additional control. Fig. 5A shows representative examples of the inward current responses to GABA, acetylcholine, nicotine, morantel, levamisole, pyrantel, and bephenium recorded at −40 mV in untreated worms and in unc-29+unc-38 dsRNA-treated worms. We compared effects of the dsRNA on each of the agonist responses. Fig. 5B shows that the current responses in unc-29+unc-38 dsRNA-treated worms were significantly reduced for levamisole, pyrantel, and bephenium compared with untreated worm responses. Similar reductions were seen when we compared lacZ controls with the dsRNAtreated worms (Fig. S5) . The effects on GABA, acetylcholine, morantel, and nicotine current responses were not statistically significant, suggesting that the UNC-29 and/or UNC-38 subunits Black color data points (circles) representing control, blue color data points (squares) lacZ (nonspecific dsRNA), and red (triangles) color representing the worms treated with mixture of unc-29 and unc-38 dsRNA. n = 38 worms for all treatments, two-way ANOVA and Bonferroni post hoc tests; ***P < 0.001.
are an essential part of receptors that respond to levamisole, bephenium, and pyrantel, but these subunits have little or no part to play in the responses to the other agonists. These observations suggest that the L-type and P-type nAChRs contain UNC-38 and/or UNC-29 subunits but that the N-type and the M-type do not contain UNC-38 and/or UNC-29 subunits.
No Monepantel-Sensitive Receptors on B. malayi Muscle. Monepantel is another cholinergic anthelmintic that acts as a positive allosteric modulator of the DEG-3 family of nAChRs that may be in nematode muscle (36, 37) . We tested the effects of 1 mM choline and 10 μM monepantel on B. malayi whole-muscle currents. We found that monepantel was without effect when tested in four preparations (Fig. S6 ). These observations suggest the absence of monepantel receptors [DEG-3 nAChRs (MPLR-1, ACR-23, and ACR-20)] from B. malayi muscle.
Discussion
Despite there being a published genome of B. malayi (38) , functional and genomic studies of the modes of action of anthelmintics in filaria have been difficult, and there have been only a few successful reports of RNAi experiments in B. malayi (34, (39) (40) (41) (42) (43) (44) (45) (46) (47) . Here, we are able to describe a reliable RNAi method, using soaking in dsRNA that we have coupled with movement phenotyping and patch clamp to study the effects of cholinergic anthelmintics on adult B. malayi in vitro. Important components were the optimization of the dsRNA concentration and culture duration required for effective and selective RNAi knockdown.
We can now conduct functional genomics related to the modes of action of anthelmintics in a significant nematode parasite; there are advantages over the use of the C. elegans model, which is evolutionarily distant and does not contain "parasite genes." We are optimistic we can now explore functional properties of their other ion channels, effects of anthelmintics, and examine the role of individual or groups of selected genes in this major parasite. We did not find significant off-target effects with our lacZ controls and no significant knockdown of GAPDH, GABA, or other nicotinic channel subunit genes (Fig. 4 and Fig. S3 ).
Functional Interpretation of the Observations. We have identified four distinct (M-, L-, P-, and N-) types of cholinergic receptors on muscle of B. malayi (Fig. 3) . The dsRNA knockdown dissected out L-and P-receptors from M-and N-receptors, and derquantel dissected out M-, P-, L-, and N-receptor populations. The names for these receptor types is based on the agonists we used with derquantel as the antagonist. We point out that the agonists are not exclusive to one receptor and will have some overlapping actions, depending on the agonist concentration and receptor type. nAChRs are composed of five subunits with the ion channel in the center as the pore. These ion channels, if they are composed of five identical subunits, are described as homomeric or heteromeric if these subunits are different. In C. elegans (31, 35) , only two types of muscle nAChR are recognized: the L-type, which appears to be composed of UNC-63, UNC-38, UNC-29, LEV-1, and LEV-8 subunits, and the N-type, which appears to be composed of ACR-16 subunits. There are also a range of ACR-16-like subunits, including ACR-21 present in other tissues of C. elegans (48, 49) , which are anticipated to form homomeric receptors in vivo. In animal parasitic nematodes, there is a greater diversity in the nAChRs that are present on somatic muscle. In Ascaris suum, there are three separable muscle subtypes [N-, L-, and B- (27) ] and four types in Oesophagostomum dentatum (11) . Xenopus expression experiments suggest in Haemonchus contortus and Oesophagostomum dentatum that: the L-type (L-AChR-1) is composed of UNC-63, UNC-38, UNC-29, and ACR-8 subunits; the P-type (L-AChR-2) is composed of UNC-63, UNC-38, and UNC-29 subunits (10, 25) ; and the N-type in Ascaris suum is composed of ACR-16 subunits (14, 35, 50) . A fourth type of muscle nAChR selectively activated by morantel and composed of ACR-26 and ACR-27 subunits has been described in Haemonchus contortus (51) . We anticipate that our M-type could include nAChRs involving ACR-26 subunits and ACR-27 or other subunits.
One of the limitations of these earlier studies has been the difficulty in performing RNAi and in vivo electrophysiology on the same parasite for functional genomic studies. Here, we have been able to overcome those difficulties and were able to knockdown unc-38 and unc-29 mRNA to show that the L-types, which are sensitive to levamisole, and/or the P-types, which are sensitive pyrantel, are required to drive spontaneous motility of B. malayi. In contrast, knockdown of acr-16+acr-26 does not inhibit the motility phenotype, suggesting that the M-and N-type receptors do not drive motility. We also point out that derquantel was most potent as an inhibitor of the M-type of receptors and derquantel only had a weak effect on motility, supporting the view that the M-receptors do not drive motility. This lack of effect on motility is interesting because it raises the question of the function of the M-and N-receptors in the muscle. nAChR subunit genes are not only expressed in body muscle, but they are widely distributed and found on embryos, spermatogonia, and lateral cord of B. malayi (52) ; the distribution suggests that the ion-channels function in development and metabolism and not just in muscle control. nAChRs have functions outside the neuromuscular system in mammals where they are also involved in immune responses, metabolism, and early development (53) . Thus, M-and N-receptors may have paracrine, immune response, and/or developmental functions in parasitic nematodes. Anthelmintics like derquantel targeting M-or other anthelmintics targeting N-receptors could have effects on Only levamisole, pyrantel, and bephenium responses were significantly inhibited when 29+38 dsRNA worm's responses were compared with untreated control dsRNA-treated worm currents: one-way ANOVA and Bonferroni post hoc tests: ***P < 0.001; **P < 0.01; *P < 0.05. Ach, acetylcholine; Bep, bephenium; Lev, levamisole; Mor, morantel; Nic, nicotine; Pyr, pyrantel.
development, responses to host attack, and adaptations to different environments in the host rather than just effects on motility. Future phenotypic anthelmintic screens for drug development should include growth and developmental assays as well as release of excretory substances and exosomes assay (54) (55) (56) in addition to motility screens.
Materials and Methods
Details of our methods are provided in SI Materials and Methods and are outlined here. Female B. malayi were used for studying functional genomics by using: (i) Worminator for motility phenotyping; (ii) single-cell RT-PCR to identify nAChR subunit genes expression; (iii) dsRNA for knockdown of UNC-38+UNC-29 subunits of nematode levamisole and pyrantel receptors and ACR-16+ACR-26 subunits of nicotine and morantel receptors; and (iv) wholecell patch clamp to study functional properties of muscle nAChRs.
